Aptus Capital Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $315K | Buy |
8,205
+1,426
| +21% | +$54.8K | ﹤0.01% | 798 |
|
|
2025
Q1 | $263K | Sell |
6,779
-236
| -3% | -$9.14K | ﹤0.01% | 802 |
|
|
2024
Q4 | $240K | Sell |
7,015
-871
| -11% | -$29.8K | ﹤0.01% | 828 |
|
|
2024
Q3 | $322K | Buy |
7,886
+2,365
| +43% | +$96.7K | ﹤0.01% | 643 |
|
|
2024
Q2 | $213K | Buy |
5,521
+646
| +13% | +$24.9K | ﹤0.01% | 718 |
|
|
2024
Q1 | $209K | Buy |
+4,875
| New | +$209K | ﹤0.01% | 715 |
|
|
2020
Q1 | – | Sell |
-57,718
| Closed | -$3.39M | – | 424 |
|
|
2019
Q4 | $3.39M | Buy |
57,718
+10,444
| +22% | +$613K | 0.24% | 48 |
|
|
2019
Q3 | $2.52M | Buy |
+47,274
| New | +$2.52M | 0.14% | 69 |
|